CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRSP — CRISPR Therapeutics AG
CIK 884546
SAN FRANCISCO, CA
Position in CRSP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,441,831
-$4,580,913 QoQ
Shares Held
1,039,349
+0.9% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 99.99518929637686.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0048107036231333266.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. CRSP ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CRSP
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,441,831 | 1,039,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,022,744 | 1,030,182 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $63,887,753 | 985,770 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $45,391,042 | 933,204 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $24,281,732 | 713,539 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $28,458,539 | 723,032 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $34,024,842 | 724,241 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $38,757,900 | 717,606 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $45,612,126 | 669,192 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $40,879,239 | 653,023 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $28,956,005 | 637,938 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $36,306,355 | 646,711 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $28,982,343 | 640,777 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,060,471 | 641,094 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $40,655,411 | 622,118 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,155,434 | 348,123 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,270,984 | 354,803 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||